Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data on which this study was based are available from the corresponding author upon reasonable request. Supporting Information Filename Description bjo70385-sup-0001-Supinfo1.docxWord 2007 document , 140.3 KB Supplementary Table 1. Overview of safety and tolerability (safety set). Supplementary Table 2. Drug-related adverse events occurring in ≥ 10% of participants in any treatment group (safety set).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jae-yeon
Contact Jae-yeon, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack